Hironori Koga

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

Takumi Kawaguchi, Takafumi Yoshida, Masaru Harada et al. · American Journal Of Pathology · 2004 · 533 citations · Full text

Signal Transduction, Viral Hepatitis, Immunology +7

Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration

Yoshinori Fukui, Osamu Hashimoto, Terukazu Sanui et al. · Nature · 2001 · 443 citations

Lymphocyte Migration, Lymphocyte Development, Cell Signaling +9

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Expression of Cyclooxygenase–2 in Human Hepatocellular Carcinoma: Relevance to Tumor Dedifferentiation

Hironori Koga, Shotaro Sakisaka, Masahito Ohishi et al. · Hepatology · 1999 · 401 citations · Full text

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

Oncology, Hepatology, Medicine +10